Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.
William
Basem M
BM
D000369:Aged, 80 and over; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D019774:Blood Coagulation Factor Inhibitors / Q000502:physiology; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D005165:Factor V / Q000037:antagonists & inhibitors*; D015942:Factor VIIa / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005165:Factor V; C103587:recombinant FVIIa; D015942:Factor VIIa